IP Due Diligence for Life Sciences Company
Performed IP due diligence and authored multiple noninfringement and invalidity opinions to position a small life sciences company developing and marketing biological wound healing materials for a possible IPO and eventual acquisition for $300 million, plus an additional $100 million upon reaching certain growth milestones.